These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19789371)

  • 1. The safety of H(2)-blockers use during pregnancy.
    Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Uziel E; Levy A
    J Clin Pharmacol; 2010 Jan; 50(1):81-7. PubMed ID: 19789371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of metoclopramide use in the first trimester of pregnancy.
    Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
    N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.
    Daniel S; Matok I; Gorodischer R; Koren G; Uziel E; Wiznitzer A; Levy A
    J Rheumatol; 2012 Nov; 39(11):2163-9. PubMed ID: 22984274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
    Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
    Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further analysis of the risk of adverse birth outcome after maternal use of fluoroquinolones.
    Wogelius P; Nørgaard M; Gislum M; Pedersen L; Schønheyder HC; Sørensen HT
    Int J Antimicrob Agents; 2005 Oct; 26(4):323-6. PubMed ID: 16144758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The health consequences of teenage fertility.
    Makinson C
    Fam Plann Perspect; 1985; 17(3):132-9. PubMed ID: 2431924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of first trimester exposure to H2 blockers.
    Lagace E
    J Fam Pract; 1996 Oct; 43(4):342-3. PubMed ID: 8874364
    [No Abstract]   [Full Text] [Related]  

  • 8. Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists.
    Levy A; Matok I; Gorodischer R; Sherf M; Wiznitzer A; Uziel E; Koren G
    J Clin Pharmacol; 2012 Jan; 52(1):78-83. PubMed ID: 21343345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivmecillinam and adverse birth and neonatal outcomes: a population-based cohort study.
    Vinther Skriver M; Nørgaard M; Pedersen L; Carl Schønheyder H; Sørensen HT
    Scand J Infect Dis; 2004; 36(10):733-7. PubMed ID: 15513399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of perinatal mortality associated with asthma during pregnancy.
    Breton MC; Beauchesne MF; Lemière C; Rey E; Forget A; Blais L
    Thorax; 2009 Feb; 64(2):101-6. PubMed ID: 19008298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal safety of macrolides.
    Bahat Dinur A; Koren G; Matok I; Wiznitzer A; Uziel E; Gorodischer R; Levy A
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3307-11. PubMed ID: 23650169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
    Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
    Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
    J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant.
    Thaithumyanon P; Limpongsanurak S; Praisuwanna P; Punnahitanon S
    J Med Assoc Thai; 2005 Nov; 88(11):1506-13. PubMed ID: 16471094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.
    Goldberg O; Koren G; Landau D; Lunenfeld E; Matok I; Levy A
    J Clin Pharmacol; 2013 Sep; 53(9):991-5. PubMed ID: 23873250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of low birth weight: a community based prospective cohort study.
    Hirve SS; Ganatra BR
    Indian Pediatr; 1994 Oct; 31(10):1221-5. PubMed ID: 7875782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of fetal exposure to proton-pump inhibitors during pregnancy.
    Matok I; Levy A; Wiznitzer A; Uziel E; Koren G; Gorodischer R
    Dig Dis Sci; 2012 Mar; 57(3):699-705. PubMed ID: 22038541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of pregnancy after first trimester exposure to H2 receptor antagonists.
    Koren G; Zemlickis DM
    Am J Perinatol; 1991 Jan; 8(1):37-8. PubMed ID: 1670987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of cetirizine during pregnancy. A prospective observational cohort study.
    Weber-Schoendorfer C; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiglaucoma medications during pregnancy and the risk of low birth weight: a population-based study.
    Ho JD; Hu CC; Lin HC
    Br J Ophthalmol; 2009 Oct; 93(10):1283-6. PubMed ID: 19520696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.